Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Capital Expenditures (2019 - 2025)

Summit Therapeutics' Capital Expenditures history spans 7 years, with the latest figure at -$202000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 245.32% year-over-year to -$202000.0; the TTM value through Dec 2025 reached $291000.0, up 109.35%, while the annual FY2025 figure was $291000.0, 109.35% up from the prior year.
  • Capital Expenditures reached -$202000.0 in Q4 2025 per SMMT's latest filing, down from $421000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $422000.0 in Q1 2025 to a low of -$350000.0 in Q2 2025.
  • Average Capital Expenditures over 5 years is $78315.8, with a median of $39000.0 recorded in 2021.
  • The largest YoY upside for Capital Expenditures was 10450.0% in 2025 against a maximum downside of 8650.0% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $120000.0 in 2021, then tumbled by 108.33% to -$10000.0 in 2022, then soared by 120.0% to $2000.0 in 2023, then surged by 6850.0% to $139000.0 in 2024, then tumbled by 245.32% to -$202000.0 in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Capital Expenditures are -$202000.0 (Q4 2025), $421000.0 (Q3 2025), and -$350000.0 (Q2 2025).